BridgeBio Pharma, Inc. (NASDAQ:BBIO) Q4 2025 Earnings Call Transcript February 24, 2026
BridgeBio Pharma, Inc. misses on earnings expectations. Reported EPS is $-1.00697 EPS, expectations were $-0.75.
Operator: We will be going live in five, four, three. Good afternoon. I will be your conference operator today. All lines have been placed on mute to prevent any background noise. After the company’s remarks, there will be a question-and-answer session. If you would like to ask a question,...
